Neurodevelopmental disorder in a patient with HMBS and SCN3A variants—A possibly blended phenotype further delineating autosomal recessive HMBS related disease
Authors:
- 3 April 2024
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (8) , e63617
Abstract
Monoallelic pathogenic HMBS variants are a well‐established cause of acute intermittent porphyria (AIP), whereas biallelic pathogenic variants may cause HMBS ‐related leukoencephalopathy which remains a poorly characterized disorder. We describe an 8‐year‐old girl with hypotonia, hearing impairment, horizontal nystagmus, bilateral strabismus, impaired visual acuity, and optic nerve atrophy. She had no epilepsy but sleep electroencephalogram showed paroxysmal changes in the right hemisphere with secondary generalizations. Brain magnetic resonance imaging was unremarkable apart from a few small white matter hyperintensities. Exome sequencing (ES) initially prioritized a SCN3A c.3822G>A de novo variant whose sole causative role was eventually questioned as not fully compatible with symptoms. ES reanalysis revealed a homozygous c.674G>A HMBS variant. In the monoallelic form this variant is a known cause of AIP, whereas in trans with another HMBS pathogenic variant it was associated with the HMBS ‐related leukoencephalopathy in four individuals. Despite lack of signs/symptoms of porphyria, literature analysis suggested that HMBS c.674G>A likely contributed to the disease either as the sole cause or together with SCN3A c.3822G>A as a part of blended phenotype. Our report adds to the relatively small number of described cases of HMBS ‐related leukoencephalopathy and emphasizes that autosomal recessive form of HMBS disease can be present in the absence of porphyria symptoms.Keywords
This publication has 28 references indexed in Scilit:
- Expanding the clinical and radiological phenotypes of leukoencephalopathy due to biallelic HMBS mutationsAmerican Journal of Medical Genetics Part A, 2021
- SCN3A‐Related Neurodevelopmental Disorder: A Spectrum of Epilepsy and Brain MalformationAnnals of Neurology, 2020
- Neurodevelopmental disorder associated with de novo SCN3A pathogenic variants: two new cases and review of the literatureBrain and Development, 2020
- Sodium Channel SCN3A (NaV1.3) Regulation of Human Cerebral Cortical Folding and Oral Motor DevelopmentNeuron, 2018
- Opposing Effects on Na V 1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile SeizuresBiological Psychiatry, 2017
- SCN3A deficiency associated with increased seizure susceptibilityNeurobiology of Disease, 2017
- Acute Intermittent Porphyria: Predicted Pathogenicity ofHMBSVariants Indicates Extremely Low Penetrance of the Autosomal Dominant DiseaseHuman Mutation, 2016
- Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizuresGene, 2013
- Actionable, Pathogenic Incidental Findings in 1,000 Participants’ ExomesThe American Journal of Human Genetics, 2013
- Homozygous acute intermittent porphyria: compound heterozygosity for adjacent base transitions in the same codon of the porphobilinogen deaminase geneHuman Genetics, 1992